Sign inJoin waitlistJoin the waitlist

Sarah Davis

Associate Professor · University of Colorado School of Medicine

Credentials: · · ·

History

University of Colorado School of Medicine
Present

Medical Oncology
2010–2012
Internal Medicine
2007–2010
University of Missouri School of Medicine
2003–2007

Research

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Clinical Cancer Research · 2019 · Last of 27 authors · 225 citations
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
Journal for ImmunoTherapy of Cancer · 2019 · 152 citations
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
Journal of Clinical Investigation · 2021 · 104 citations

Wells Messersmith
19 papers
Christopher Lieu
17 papers
Gail Eckhardt
14 papers
Jennifer Diamond
11 papers
Alexis Leal
9 papers
SL
Stephen Leong
7 papers
Antonio Jimeno
5 papers
Sunnie Kim
5 papers
AC
Anna Capasso
4 papers
Bradley Corr
4 papers
Hannah Robinson
4 papers · 4 as a fellow
RL
Robert Lentz
4 papers